Fmoc-D-Nle-OH,
Fmoc-D-norleucine,
112883-41-7,
(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hexanoic acid,
D-Norleucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-,
MFCD00155639,
J-300349,
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid,
AK-41275,
AC1MBSTL,
PubChem14959,
D-Norleucine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-,
SCHEMBL7420121,
CTK8B6105,
KS-00000IOC,
DTXSID20373243,
VCFCFPNRQDANPN-LJQANCHMSA-N,
Fmoc-D-Nle-OH, >=98.0%,
ZINC4521508,
ANW-52552,
CF-834,
AKOS015918292,
AM82589,
CS-W008273,
FCH2715160,
RTR-002490,
AJ-51424,
AS-19000,
AX8017585,
FT-0642756,
ST24047260,
ST50826269,
X4048,
883F417,
C-27815,
I14-8030,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-norleucine,
Z1982491153,
(2R)-2-[(fluoren-9-ylmethoxy)carbonylamino]hexanoic acid,
(R)-2-(9H-Fluorene-9-ylmethoxycarbonylamino)hexanoic acid,
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hexanoic acid,
(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid,
N-Fmoc-D-norleucine,
Fmoc-D-Nle-OH - 5G 5g,
C21H23NO4,
ACN-033885,
CID2756111,
N-(9-Fluorenylmethoxycarbonyl)-D-norleucine,
A7652,
2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic Acid,